Some of the stocks that may grab investor focus today are:
- NeuBase Therapeutics, Inc. NBSE reported a net loss of around $25.4 million, or $0.93 per share for the fiscal year ended September 30, 2021, versus a year-ago net loss of around $17.4 million, or $0.89 per share. NeuBase Therapeutics shares gained 0.7% to $3.08 in the after-hours trading session.
- Aeterna Zentaris Inc. AEZS named Giuliano La Fratta as Chief Financial Officer. Aeterna Zentaris shares fell 0.5% to close at $0.4202 on Thursday.
- Ares Management Corporation ARES said its subsidiary, Ares Holdings L.P., agreed to acquire AMP's PrivateMarketsCo Infrastructure Debt platform for $308 million. Ares Management shares gained 3% to settle at $81.36 on Thursday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Choosing the best broker is an important part of being a successful trader or investor
- Escalade, Incorporated ESCA appointed Walter P. Glazer, Jr. as Chief Executive Officer and President. Escalade shares rose 0.6% to close at $15.69 on Thursday.
- The Drugs Controller General of India has given Bharat Biotech’s Covaxin Emergency Use approval in the paediatric age group between 12 and 18 years. Ocugen, Inc. OCGN has the US rights to the Bharat Biotech’s vaccine candidate. Ocugen shares dropped 1.5% to $5.22 in after-hours trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in